n(6)-carboxymethyllysine has been researched along with Atrophy, Muscular, Peroneal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bierhaus, A; Erwin, S; Haslbeck, KM; Heuss, D; Kirchner, A; Nawroth, P; Neundörfer, B; Schlötzer, U | 1 |
| Bierhaus, A; Haslbeck, KM; Haslbeck, M; Heuss, D; Nawroth, P; Neundörfer, B; Schleicher, E | 1 |
| Friess, U; Haslbeck, KM; Heuss, D; Kirchner, A; Neundörfer, B; Schleicher, ED | 1 |
3 other study(ies) available for n(6)-carboxymethyllysine and Atrophy, Muscular, Peroneal
| Article | Year |
|---|---|
Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy.
Topics: Adult; Aged; Charcot-Marie-Tooth Disease; Humans; Immunohistochemistry; Interleukin-6; Lysine; Middle Aged; NF-kappa B; Oxidative Stress; Peripheral Nervous System Diseases; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sural Nerve; Vasculitis | 2004 |
The AGE/RAGE/NF-(kappa)B pathway may contribute to the pathogenesis of polyneuropathy in impaired glucose tolerance (IGT).
Topics: Aged; Biopsy; Charcot-Marie-Tooth Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glycation End Products, Advanced; Humans; Lysine; Middle Aged; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Sural Nerve | 2005 |
N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies.
Topics: Adult; Aged; Biopsy; Blotting, Western; Charcot-Marie-Tooth Disease; Diabetic Neuropathies; Female; Humans; Immunohistochemistry; Lysine; Male; Middle Aged; Oxidative Stress; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve | 2002 |